Welcome
Support Centre
11 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Is laser treatment or surgery the best way of treating varicose veins?
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN99270116
Date ISRCTN assigned10/07/2007
Local reference number(s)VS03/2281
Public titleIs laser treatment or surgery the best way of treating varicose veins?
Scientific title
AcronymN/A
Disease/condition/study domainVaricose veins
Study hypothesisEndovenous laser ablation (EVLA) produces comparable short-term results to surgery (abolition of great saphenous vein [GSV] reflux and improvement in symptoms) for the treatment of primary varicose veins due to sapheno-femoral incompetence with greater saphenous vein reflux.
Design/methodologyParallel group, non-blinded, randomised controlled trial
Research ethics reviewReceived from Leeds (West) Research Ethics Committee in May 2003 (ref: 03/052).
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Symptomatic varicose veins
2. Primary sapheno-femoral incompetence with greater saphenous vein reflux
Participants - exclusion criteria1. Unable to consent
2. Children (under 18 years)
3. Unfit for general anaesthesia
4. Recurrent varicose veins
5. Patients on long-term anticoagulation
6. Patients with anterior thigh branch of greater saphenous vein arising within 10 cm of groin and competent GSV distal to this
Patient information material
Anticipated start date05/06/2003
Anticipated end date01/12/2006
Status of trialCompleted
Target number of participants342
InterventionsEndovenous laser treatment (810 nm diode laser, Diomed) versus sapheno-femoral ligation, greater saphenous vein stripping and avulsions (surgery).
Primary outcome measure(s)1. Abolition of GSV reflux at three months (duplex ultrasound)
2. Improvement in disease-specific quality of life (Aberdeen Varicose Vein Questionnaire)
Secondary outcome measure(s)1. Time to return to work and to normal activity
2. Pain and analgesia use during first week following treatment
3. Overall satisfaction and satisfaction with cosmetic outcome
4. Generic quality of life (36-item Short Form health survey [SF-36]) at 1 and 12 weeks following treatment
5. Complications
PublicationsResults in http://www.ncbi.nlm.nih.gov/pubmed/18278775
Sources of funding1. Leeds Teaching Hospitals NHS Trust (UK)
2. Diomed Ltd (UK) - part of research fellow salary paid (£15,000 pa)
Sponsor nameLeeds Teaching Hospitals NHS Trust (UK)
Sponsor detailsLeeds Vascular Institute
The General Infirmary at Leeds
Great George Street
Leeds
United Kingdom
LS1 3EX
Sponsor websitehttp://www.leedsteachinghospitals.com/
Contact nameMr Michael Gough
Contact detailsLeeds Vascular Institute
The General Infirmary at Leeds
Great George Street
Leeds
United Kingdom
LS1 3EX
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN99270116
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central